SOLUTION NMR Experimental Data


Experimental Details
Sample Conditions
Sample Contents6mM antifungal peptide(EAFP2); 20 mM phosphate buffer,0.01 mM EDTA
Solvent90% H2O, 10% D2O
Ionic Strength20 mM Phospate Buffer
pH5.6
Pressureambient
Temperature (K)300
Experiment(s):DQF-COSY, 2D TOCSY, 2D NOESY
Sample Contents6mM antifungal peptide(EAFP2); 20 mM phosphate buffer,0.01 mM EDTA
Solvent90% H2O, 10% D2O
Ionic Strength20 mM Phospate Buffer
pH5.6
Pressureambient
Temperature (K)290
Experiment(s):2D NOESY, 2D TOCSY
Sample Contents6mM antifungal peptide(EAFP2); 20 mM phosphate buffer, 0.01 mMEDTA
Solvent100% D2O
Ionic Strength20 mM Phospate Buffer
pH5.6
Pressureambient
Temperature (K)300
Experiment(s):2D TOCSY, 2D NOESY, DQF-COSY
Spectrometer Information
Manufacturer Model Field Strength
Bruker DMX 500.0
NMR Refinement
Method torsion angle dynamics, simulated annealing
Details the structures are based on a total of 630 restraints, 594 are NOE-derived distance constraints, 16 dihedral angle restraints,20 distance restraints from hydrogen bonds.
NMR Ensemble Information
Conformer Selection Criteria structures with the least restraint violations,structures with the lowest energy
Conformers Calculated Total Number 100
Conformers Submitted Total Number 21
Representative Model Choice Rationale
1 fewest violations,lowest energy
Additional NMR Experimental Information
1 This structure was determined using standard 2D homonuclear techniques
Computation: NMR Software
# Classification Software Name Author
1 refinement CNS 1.1 Brunger, A.T. etc.
2 structure solution CNS 1.1 Brunger, A.T. etc.
3 data analysis SPARKY 3.105 Goddard, T.D. and Kneller, D.G.
4 collection XWINNMR 3.1 Bruker Corp.